EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Menopausal hormone therapy and the female brain: Leveraging neuroimaging and prescription registry data from the UK Biobank cohort

Claudia Barth iD, Liisa A M Galea, Emily G Jacobs iD, Bonnie H Lee, Lars T Westlye iD, Ann-Marie G de Lange

eLife · 29.05.2025 · 13

DOI: 10.7554/elife.99538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 29.05.2025. Verfasst von Claudia Barth und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division for Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Brain, Menopause, Hormone Replacement Therapy, Estrogen Replacement Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Norges Forskningsråd, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Menopausal hormone therapy (MHT) is generally thought to be neuroprotective, yet results have been inconsistent. Here, we present a comprehensive study of MHT use and brain characteristics in females from the UK Biobank.

Methods

19,846 females with magnetic resonance imaging data were included. Detailed MHT prescription data from primary care records was available for 538. We tested for associations between the brain measures (i.e. gray/white matter brain age, hippocampal volumes, white matter hyperintensity volumes) and MHT user status, age at first and last use, duration of use, formulation, route of administration, dosage, type, and active ingredient. We further tested for the effects of a history of hysterectomy ± bilateral oophorectomy among MHT users and examined associations by APOE ε4 status.

Results

Current MHT users, not past users, showed older gray and white matter brain age, with a difference of up to 9 mo, and smaller hippocampal volumes compared to never-users. Longer duration of use and older age at last use post-menopause was associated with older gray and white matter brain age, larger white matter hyperintensity volume, and smaller hippocampal volumes. MHT users with a history of hysterectomy ± bilateral oophorectomy showed younger gray matter brain age relative to MHT users without such history. We found no associations by APOE ε4 status and with other MHT variables.

Conclusions

Our results indicate that population-level associations between MHT use and female brain health might vary depending on duration of use and past surgical history. Funding: The authors received funding from the Research Council of Norway (LTW: 223273, 249795, 273345, 298646, 300768), the South-Eastern Norway Regional Health Authority (CB: 2023037, 2022103; LTW: 2018076, 2019101), the European Research Council under the European Union’s Horizon 2020 research and innovation program (LTW: 802998), the Swiss National Science Foundation (AMGdL: PZ00P3_193658), the Canadian Institutes for Health Research (LAMG: PJT-173554), the Treliving Family Chair in Women’s Mental Health at the Centre for Addiction and Mental Health (LAMG), womenmind at the Centre for Addiction and Mental Health (LAMG, BHL), the Ann S. Bowers Women’s Brain Health Initiative (EGJ), and the National Institutes of Health (EGJ: AG063843).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainMenopauseHormone Replacement TherapyEstrogen Replacement TherapyHumansFemaleMiddle AgedUnited KingdomAgedMagnetic Resonance ImagingNeuroimagingBiological Specimen BanksRegistriesCohort StudiesAdultGray MatterUK Biobank

Stichwörter der Autor:innen

epidemiologyglobal healthhumanmachine learningmenopausal hormone therapyneuroimagingneurosciencewomen's health

Autor:innen und Institutionen

  • Division for Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.
  • Centre for Addiction and Mental Health, Toronto, Canada.
  • Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, United States.
  • Department of Psychology, University of Oslo, Oslo, Norway.
  • Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Claudia Barth, Emily G Jacobs, Lars T Westlye

Förderung

  • European Research Council
  • Norges Forskningsråd
  • NIH HHS
  • CIHR
  • NIA NIH HHS
  • Helse Sør-Øst RHF
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Canadian Institutes of Health Research

Zitieren

APA

Barth, C., Galea, L. A. M., Jacobs, E. G., Lee, B. H., Westlye, L. T., & de Lange, A. G. (2025). Menopausal hormone therapy and the female brain: Leveraging neuroimaging and prescription registry data from the UK Biobank cohort. eLife, 13. https://doi.org/10.7554/elife.99538

Vancouver

Barth C, Galea LAM, Jacobs EG, Lee BH, Westlye LT, de Lange AG. Menopausal hormone therapy and the female brain: Leveraging neuroimaging and prescription registry data from the UK Biobank cohort. eLife. 2025;13. doi:10.7554/elife.99538

BibTeX
@article{Barth2025,
  author = {Barth, Claudia and Galea, Liisa A M and Jacobs, Emily G and Lee, Bonnie H and Westlye, Lars T and de Lange, Ann-Marie G},
  title = {Menopausal hormone therapy and the female brain: Leveraging neuroimaging and prescription registry data from the UK Biobank cohort},
  journal = {eLife},
  year = {2025},
  volume = {13},
  doi = {10.7554/elife.99538}
}
Kostenlos starten →